The purpose of ACTRIMS is to provide leadership in the field of multiple sclerosis and other demyelinating diseases.
|
|
|
|
August 2015 Newsletter Vol. 1 Issue 2
|
|
|
|
President
Suhayl Dhib-Jalbut, MD
Rutgers University
President Elect
Jack Antel, MD
McGill University
Secretary/Treasurer
Mark Freedman, MD
University of Ottawa
Past-President
Jerry S. Wolinksy, MD
University of Texas
Samuel S. Ludwin, MD
The Children's Hospital of Philadelphia
Amit Bar-Or, MD
McGill University
Peter A. Calabresi, MD, FAAN
Johns Hopkins University
Andrew Goodman, MD Johns Hopkins University
Ruth Ann Marrie, MD, PhD University of Manitoba
Robert Naismith, MD Washington University
Michael Racke, MD Ohio State University
Emmanuelle Waubant, MD, PhD University of California- San Francisco |
|
ACTRIMS Forum 2016 Program Committee
|
Co-Chairs:
Fiona Costello, MD, FRCPC
Benjamin M. Segal, MD (Co-chair)
Members:
Suhayl Dhib-Jalbut, MD
Jack Antel, MD
Jerry S. Wolinsky, MD
Jeffrey A. Cohen, MD
Peter A. Calabresi, MD
Emmanuelle Waubant, MD, PhD
|
|
Managing Director
Lynda J. Patterson, FASAE, CAE
lpatterson@actrims.org
Associate Director
Marechiel Santos-Lang
msantoslang@actrims.org
Administrative Assistant
Emily Viles
eviles@actrims.org
|
|
 |
|
|
ACTRIMS Forum 2016
Now accepting abstract submissions
|
|
ACTRIMS welcomes the submission of basic and translational abstracts for presentation at ACTRIMS Forum 2016.
ACTRIMS Forum 2016 is ACTRIMS' inaugural stand-alone meeting. This highly anticipated CME-accredited meeting stands apart from other MS meetings, offering an interactive educational and networking environment for attendees.
The ACTRIMS Forum 2016 theme is the pathogenesis, diagnosis and treatment of Progressive MS. However, submissions can be on any topic related to Multiple Sclerosis or related immunological disorders of the Central Nervous System.
Abstract submission will close on Sept. 15, 2015.
Accepted abstracts will be presented on Friday, Feb. 19, 2016 during the ACTRIMS Forum 2016 in New Orleans, Louisiana, USA.
Submission Categories:
- Biomarkers
- Clinical outcome measures
- Clinical trials
- Diagnostic criteria and differential diagnosis
- Disease modifying therapies - Risk management
- Environmental influences
- Epidemiology
- Experimental model
- Fatigue and sleep disorders
- Genetics and epigenetics
- Imaging
- Microbiome
- Neuromyelitis optica
- Neuro-ophthalmology
- Neuroprotection and neuroregeneration
- Neuropsychology and cognition
- Pathogenesis - immunology
- Pathogenesis - neurodegeneration
- Pediatric MS
- Prognostic factors
- PROs and QOL
- Rehabilitation and comprehensive care
- Reproductive aspects and pregnancy
- Symptom management
- Viruses and MS
Full Abstract Submission Guidelines
Submit an Abstract
For additional information,
visit the ACTRIMS Forum 2016 website.
|
|
|
|
Opportunities for Young Investigators at ACTRIMS Forum 2016!
|
 Young Investigator Session Abstracts submitted by presenting authors who are still in training, or who have completed their postgraduate training in 2009 or later, may be considered for an oral presentation on Feb. 18, 2016. Candidates may be residents, postdoctoral fellows or junior faculty. Educational Grants A limited number of ACTRIMS Forum 2016 educational grants will be awarded to young investigators whose abstracts are accepted for a platform or poster presentation. Young investigators include students, residents, postdoctoral fellows and junior faculty. In general, junior faculty should have completed their postgraduate training (residency or fellowship) in 2009 or later in order to qualify for an educational grant. Recipients of educational grants will be notified in November 2015, after notification of abstract acceptance. Those who are awarded an educational grant will receive $600 USD and complimentary registration to the meeting (a value of $250). Best Young Investigator Posters Prizes will be awarded for the two best poster presentations ($1,500 USD each) as determined by an ACTRIMS-appointed judging committee. Best Young Investigator Oral Presentations One prize ($2,000 USD) will be awarded for the best oral presentation given by a young investigator, as determined by an ACTRIMS-appointed judging committee. |
ACTRIMS Forum 2016 is ACCME-accredited
|
|
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Interstate Postgraduate Medical Association (IPMA) and ACTRIMS. The IPMA is accredited by the ACCME to provide continuing medical education for physicians. The Interstate Postgraduate Medical Association designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credit(s)™.
|
|
ACTRIMS establishes Kenneth P. Johnson Memorial Lecture
|
|
| Kenneth P. Johnson
1932-2011 |
The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) is proud to present an annual lecture named in honor of the late Kenneth P. Johnson, M.D. The lecture provides an opportunity for ACTRIMS audiences to hear from a prestigious clinician or researcher selected for his/her knowledge, accomplishments and contributions related to multiple sclerosis. Dr. Ken Johnson was one of the world's leading innovators in MS research and treatment. He was a distinguished neurologist who had been a leader in the movement to end multiple sclerosis for more than four decades. In 1996, he spearheaded the foundation of ACTRIMS®. The first Kenneth P. Johnson Memorial Lecture will be presented by ACTRIMS Past-President, Jerry Wolinsky, M.D., during the inaugural ACTRIMS Forum, Feb. 18-20, 2016 in New Orleans, Louisiana, USA. Wolinsky will speak about the current challenges facing the management of progressive phases of MS.
|
|
ACTRIMS Symposium at FOCIS 2015
|
|
On June 24, ACTRIMS held a satellite symposium during the 2015 FOCIS Annual Meeting in San Diego, California. The theme of the symposium was CNS Autoimmune Disease and the Innate Immune System: Novel Roles of Pro-inflammatory and Regulatory Myeloid Cells. Dr. Benjamin M. Segal facilitated the sessions that discussed Granulocytes in Autoimmune Demyelinating Disease and Polarized Monocytes, Macrophages and Microglial Subsets: Implications for Pathogenesis, Immunoregulation and Repair in MS.
Speakers of the symposium included Luc Vallieres, Ph.D. of the Centre Hospitalier Université Laval, Quebec; Julie Rumble, Ph.D., University of Michigan; Melissa Brown, Ph.D., Northwestern University, Chicago; Etty Benveniste, Ph.D., University of Alabama, Jack Antel, M.D., McGill University, Montreal; Ari Waisman, Ph.D., Johannes Gutenberg-University Mainz and Veronique Miron, Ph.D., University of Edinburgh. Access the abstracts of the talks.
|
|
ASNI: 1-2 October 2015 in Calgary, Alberta Canada
ECTRIMS: 7-10 October 2015 in Barcelona, Spain
ICCBT: 20-21 November 2015 in Lisbon, Portugal
|
|
|
|
|
